Modifications decrease hepatic steatosis in Taiwanese with metabolic-associated fatty liver disease
Name:
TheKaohsiungJofMedScie_2022_Liu.pdf
Size:
1.345Mb
Format:
PDF
Description:
Final Published Version
Author
Liu, T.-T.Qiu, H.
Liu, S.-Y.
Chien, C.
Wang, J.-H.
Wong, M.-W.
Yi, C.-H.
Lin, L.
Lei, W.-Y.
Liang, S.-W.
Hung, J.-S.
Huang, J.-F.
Chen, C.-L.
Han, M.A.T.
Affiliation
Division of Gastroenterology and Hepatology, Department of Medicine, Banner University Medical Center, University of ArizonaIssue Date
2022Keywords
fatty liverlifestyle intervention
nonalcoholic fatty liver disease
nonalcoholic steatohepatitis
weight loss
Metadata
Show full item recordPublisher
John Wiley and Sons IncCitation
Liu, T.-T., Qiu, H., Liu, S.-Y., Chien, C., Wang, J.-H., Wong, M.-W., Yi, C.-H., Lin, L., Lei, W.-Y., Liang, S.-W., Hung, J.-S., Huang, J.-F., Chen, C.-L., & Han, M. A. T. (2022). Modifications decrease hepatic steatosis in Taiwanese with metabolic-associated fatty liver disease. Kaohsiung Journal of Medical Sciences.Rights
Copyright © 2022 The Authors. The Kaohsiung Journal of Medical Sciences published by John Wiley & Sons Australia, Ltd on behalf of Kaohsiung Medical University. This is an open access article under the terms of the Creative Commons Attribution License.Collection Information
This item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at repository@u.library.arizona.edu.Abstract
Metabolic-associated fatty liver disease (MAFLD) is a growing global problem associated with increasing obesity prevalence. Lifestyle modifications are currently recommended, including weight reduction, exercise, and diet control. This study evaluated the short-term effect of lifestyle modifications on transient elastography (TE) values in an obese population with MAFLD. Thirty-two MAFLD patients were recruited for this prospective study and all subjects participated in a 3-month program of lifestyle modification. Sequential demographic parameters and biochemical tests were compared before and after program completion. Liver fat and fibrosis changes were measured using TE with controlled attenuated parameter (CAP) and liver stiffness measurements (LSM). The mean age was 38.7 years old (10 males). The body weight (88.09 kg vs. 80.35 kg), body mass index (32.24 kg/m2 vs. 29.4 kg/m2), waist (103.19 cm vs. 95.75 cm), and hip circumference (111.67 cm vs. 104.75 cm), and blood pressure (128/78 mmHg vs. 119/71 mmHg) significantly improved before and after the intervention, respectively. Aspartate aminotransaminase (24.06 U/L vs. 18.91 U/L), alanine aminotransaminase (33 U/L vs. 23.72 U/L), creatinine (0.75 mg/dl vs. 0.70 mg/dl), cholesterol (176.41 mg/dl vs. 166.22 m/dl), gamma-glutamyl transferase (26.59 IU/L vs. 19.81 IU/L), and low-density lipoprotein cholesterol (115.63 mg/dl vs. 103.19 mg/dl) also improved after the 3-month intervention. The average CAP significantly decreased after intervention (297.5 dB/m vs. 255.0 dB/m), however, no significant difference in LSM was observed (5.24 kPa vs. 4.82 kPa). The current study suggests that short-term lifestyle modification can effectively improve hepatic steatosis, and TE may serve as a monitoring tool for therapeutic intervention. © 2022 The Authors. The Kaohsiung Journal of Medical Sciences published by John Wiley & Sons Australia, Ltd on behalf of Kaohsiung Medical University.Note
Open access journalISSN
1607-551XPubMed ID
35993503Version
Final published versionae974a485f413a2113503eed53cd6c53
10.1002/kjm2.12580
Scopus Count
Collections
Except where otherwise noted, this item's license is described as Copyright © 2022 The Authors. The Kaohsiung Journal of Medical Sciences published by John Wiley & Sons Australia, Ltd on behalf of Kaohsiung Medical University. This is an open access article under the terms of the Creative Commons Attribution License.
Related articles
- Usefulness of Transient Elastography for Non-Invasive Diagnosis of Liver Fibrosis in Pediatric Non-Alcoholic Steatohepatitis.
- Authors: Kwon YD, Ko KO, Lim JW, Cheon EJ, Song YH, Yoon JM
- Issue date: 2019 Jun 17
- Assessment of transient elastography in diagnosing MAFLD and the early effects of sleeve gastrectomy on MAFLD among the Chinese population.
- Authors: Hu R, Wu B, Wang C, Wu Z, Zhang X, Chen X, Lu G, Yuan K
- Issue date: 2024 Apr 1
- Changes in Transient Elastography with Glucagon-Like Peptide-1 Receptor Agonist Use in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Real-World Retrospective Analysis.
- Authors: Akhverdyan N, Wieland A, Sullivan S, Lindsay M, Swartwood S, Arndt G, Kaizer LK, Jensen T
- Issue date: 2024 Oct
- Saroglitazar for Nonalcoholic Fatty Liver Disease: A Single Centre Experience in 91 Patients.
- Authors: Padole P, Arora A, Sharma P, Chand P, Verma N, Kumar A
- Issue date: 2022 Mar-Apr
- Transient elastography for the prevalence of non-alcoholic fatty liver disease in patients with type 2 diabetes: Evidence from the CORDIAL cohort study.
- Authors: Alfadda AA, Sherbeeni SM, Alqutub AN, Aldosary AS, Aldaghri NM, Taylor-Robinson SD, Alqahtani SA, Gul R, Almaghamsi AM
- Issue date: 2022 Nov-Dec

